|
"Argos plans to explore a wide range of strategic alternatives that may include a potential merger or sale of the Company, among other potential alternatives that could maximize both near and long-term value for our shareholders."
|
Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
86 | Argos Therapeutics a strong buy rating.... | Balu4u | Vassago | 25.04.21 02:12 |